Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Allison M. Wing, a director at Casey’s General Stores Inc. (NASDAQ:CASY), executed a sale of 530 common shares on July 8, 2026, at a price of $837.58 per share, totaling approximately $443,917. The transaction follows a period of significant stock appreciation, with CASY trading near $823, marking a 58% gain over the past year and a 49% year-to-dat…
Stephen P. Bramlage Jr., Chief Financial Officer of Casey's General Stores Inc. (NASDAQ:CASY), sold 5,700 shares of the company's common stock on July 8, 2026, for approximately $4.78 million at a price of $838.16 per share. The transaction occurs as the stock has delivered a 58% return over the past year, currently trading at $823.12 with a market…
Koschel Williams Ena, Chief Operating Officer at Casey’s General Stores Inc. (NASDAQ:CASY), executed a sale of 2,800 shares on July 9, 2026, totaling approximately $2,334,332 at $833.69 per share. The transaction reduces her direct holdings to 21,969 shares, while she retains 419 indirect shares via a 401k plan and multiple restricted stock units (…
Robert George Culp IV, President and CEO of Culp Inc. (NYSE:CULP), executed a direct purchase of 2,768 shares on July 9, 2026, valued at $9,217. The transaction, priced at $3.33 per share, was facilitated through the company's 401(k) plan administrator. This acquisition brings Mr. Culp's total direct ownership to 424,795 shares, including holdings …
UroGen Pharma Ltd. (NASDAQ: URGN) Chief Medical Officer Mark Schoenberg completed a $400,000 liquidation of 10,000 ordinary shares on July 9, 2026. The transaction, executed at a weighted average price of $40.00 per share, marks the conclusion of a Rule 10b5-1(c) trading plan established on August 15, 2025. This sale occurs as URGN trades near its …
Michael James Hogan, serving as the Chief Strategy Officer at GLOBALFOUNDRIES Inc. (NASDAQ:GFS), has executed a series of share divestments totaling $180,430. The transactions, conducted on July 8 and July 9, 2026, were carried out under the framework of a Rule 10b5-1 trading plan. This strategic exit coincides with a period of substantial market p…
Brad Allan Weeks, serving as president of VIVOS Inc, has expanded his direct ownership in the company through recent equity purchases. The transactions, documented in a recent Securities and Exchange Commission filing, reveal a cumulative investment of $4,800. This insider activity unfolds against a backdrop of significant short-term price apprecia…
Horizon Kinetics Asset Management LLC, a significant shareholder in Texas Pacific Land Corp (NYSE:TPL), has acquired an additional 1 share of the company's common stock, bringing its direct ownership to 3,263,672 shares. This transaction follows a period of strong financial results for TPL, which reported first-quarter earnings and revenue that exc…
Horizon Kinetics Asset Management LLC, a significant shareholder and the investment adviser to RENN Fund, Inc. (NASDAQ:RCG), has increased its direct ownership in the company. On July 9, 2026, the Delaware limited liability company acquired 756 shares of common stock valued at $2,283. This transaction brings the firm's total direct stake to 932,664…
Scot Cohen, Executive Chairman and CEO of WRAP Technologies, Inc. (NASDAQ:WRAP), recently increased his stake in the company through a significant stock purchase, according to an amended filing with the Securities and Exchange Commission. On July 8, 2026, Mr. Cohen acquired 209,353 shares of WRAP Technologies common stock. The shares were purchased…
Ron-Bigger Shulamit, Chief Operating Officer of Aktis Oncology, Inc. (NASDAQ: AKTS), sold approximately $1.39 million worth of common stock on July 8, 2026, following the exercise of stock options. The transaction involved the acquisition of 50,000 shares at $3.66 per share and their subsequent sale in open market transactions ranging from $26.52 t…
Czibere Akos, the Chief Medical Officer at Aktis Oncology, Inc. (NASDAQ: AKTS), executed a series of stock transactions on July 8, 2026, resulting in the sale of 50,000 shares. The sales, totaling approximately $1.39 million, were preceded by the exercise of stock options at a significantly lower price point. Following these transactions, the execu…
American Eagle Outfitters director Noel Spiegel executed a transaction on July 7, 2026, selling 2,892 shares of common stock at a weighted average price of $16.78 per share. The transaction resulted in a total value of $48,527. Following this sale, Mr. Spiegel holds zero direct shares of the company. This divestment occurs as the retailer navigates…
American Eagle Outfitters Inc. (NASDAQ: AEO) director Cary D. McMillan executed a sale of 2,892 common shares on July 7, 2026, at a price of $16.775 per share, totaling $48,513. This transaction resulted in McMillan holding zero direct shares of the company. The sale occurred as AEO stock traded at $16.68, reflecting a 37% decline over the past six…
Nicholas S. Schorsch, a 10% owner of American Strategic Investment Co. (NASDAQ:NYC), along with affiliated entities, has executed a significant insider purchase, acquiring Class A common stock valued at $76,240. This acquisition takes place as the stock trades at $8.49, reflecting a near 9% decline over the preceding week. The transaction highlight…
Insiders tied to Stratus Properties Inc. (NASDAQ: STRS) have executed significant share sales as the company moves forward with a complete liquidation and dissolution. The transactions coincide with the firm's ongoing asset disposals, including the recent sale of the Jones Crossing retail component, and the initiation of a liquidating distribution …
Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ: UTHR), sold approximately $5.24 million worth of common stock on July 9, 2026. The sale of 9,500 shares occurred after the exercise of an equal number of stock options, with prices ranging from $547.61 to $555.77 per share. The transactions were executed under a 10b5-1 t…
Insight Holdings Group, LLC and its affiliated investment funds executed a significant divestment of Hinge Health, Inc. (NASDAQ:HNGE) equity, selling a combined total of 426,171 Class A Common Stock shares. The transactions, valued at approximately $38.4 million, were completed over two trading days in July 2026. This sale activity coincides with H…
Christopher M. Hall, Chief Executive Officer of Personalis, Inc. (NASDAQ:PSNL), executed a sale of 100,000 shares of common stock on July 9, 2026, realizing approximately $1.5 million in proceeds. The transaction was facilitated through a Rule 10b5-1 trading plan, which also involved the exercise of stock options on the same day. This executive act…
Entities affiliated with Lightspeed Venture Partners, including Lightspeed Management Company and Lightspeed Venture Partners XII, executed sales of Netskope Inc. (NASDAQ:NTSK) Class A Common Stock totaling approximately $2.8 million between July 8 and July 9, 2026. These transactions followed significant internal share conversions within the Light…
CoreWeave Inc. (NASDAQ: CRWV) CEO and President Michael N. Intrator executed a series of stock sales totaling approximately $30.8 million on July 7 and July 8, 2026. The transactions, conducted under a pre-arranged Rule 10b5-1 trading plan established in November 2025, involved the liquidation of 369,489 Class A Common Stock shares. This activity c…
Jonathan M. Craig, Managing Director and Head of Retail Investing at Charles Schwab Corp. (NYSE:SCHW), executed a $2.218 million sale of 21,750 shares on July 7, 2026. The transaction, facilitated through a trust under a Rule 10b5-1 trading plan, aligns with the company's recent reporting of a 27% year-over-year increase in total client assets to $…
CoreWeave, Inc. (NASDAQ: CRWV) Chief Financial Officer Nitin Agrawal has disclosed the sale of 3 Class A Common Stock shares through a pre-arranged trading plan. The transaction, reported via a Form 4 filing with the Securities and Exchange Commission, highlights routine executive liquidity events against a backdrop of heightened analyst scrutiny a…
Nayaab Islam, President and Chief Product Officer at StubHub Holdings, Inc., executed a stock sale involving 2,800 shares of the company's Class A Common Stock on July 7, 2026. The transaction, valued at approximately $39,214, was conducted under a pre-existing Rule 10b5-1 trading plan adopted earlier in the year. This divestment follows a period o…
Mark Streams, Executive Vice Chairman and Chief Legal Officer at StubHub Holdings, Inc. (NASDAQ: STUB), executed a sale of 400 shares of the company's Class A Common Stock on July 7, 2026. The transaction, valued at $5,603, was conducted under a Rule 10b5-1 trading plan established in December 2025. Following the sale, Streams retains a direct hold…
